Annual Shareholders Equity
$57.09 M
-$101.69 M-64.05%
31 December 2023
Summary:
Cara Therapeutics annual stockholders equity is currently $57.09 million, with the most recent change of -$101.69 million (-64.05%) on 31 December 2023. During the last 3 years, it has fallen by -$191.92 million (-77.07%). CARA annual shareholders equity is now -77.07% below its all-time high of $249.00 million, reached on 31 December 2020.CARA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$707.00 K
-$10.89 M-93.90%
30 September 2024
Summary:
Cara Therapeutics quarterly stockholders equity is currently $707.00 thousand, with the most recent change of -$10.89 million (-93.90%) on 30 September 2024. Over the past year, it has dropped by -$84.94 million (-99.17%). CARA quarterly shareholders equity is now -99.72% below its all-time high of $249.00 million, reached on 31 December 2020.CARA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.0% | -99.2% |
| 3 y3 years | -77.1% | -99.7% |
| 5 y5 years | -57.3% | -99.7% |
CARA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -77.1% | at low | -99.7% | at low |
| 5 y | 5 years | -77.1% | at low | -99.7% | at low |
| alltime | all time | -77.1% | +2240.5% | -99.7% | at low |
Cara Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $707.00 K(-93.9%) |
| June 2024 | - | $11.60 M(-61.1%) |
| Mar 2024 | - | $29.80 M(-47.8%) |
| Dec 2023 | $57.09 M(-64.0%) | $57.09 M(-33.3%) |
| Sept 2023 | - | $85.64 M(-21.4%) |
| June 2023 | - | $108.93 M(-20.3%) |
| Mar 2023 | - | $136.60 M(-14.0%) |
| Dec 2022 | $158.78 M(-30.2%) | $158.78 M(-14.1%) |
| Sept 2022 | - | $184.82 M(-9.6%) |
| June 2022 | - | $204.42 M(+0.2%) |
| Mar 2022 | - | $204.12 M(-10.3%) |
| Dec 2021 | $227.52 M(-8.6%) | $227.52 M(+9.8%) |
| Sept 2021 | - | $207.19 M(+1.8%) |
| June 2021 | - | $203.47 M(-11.7%) |
| Mar 2021 | - | $230.46 M(-7.4%) |
| Dec 2020 | $249.00 M(+33.4%) | $249.00 M(+94.8%) |
| Sept 2020 | - | $127.85 M(-9.3%) |
| June 2020 | - | $140.93 M(-12.2%) |
| Mar 2020 | - | $160.47 M(-14.1%) |
| Dec 2019 | $186.71 M(+39.7%) | $186.71 M(-11.9%) |
| Sept 2019 | - | $211.89 M(+112.9%) |
| June 2019 | - | $99.55 M(-13.1%) |
| Mar 2019 | - | $114.52 M(-14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $133.63 M(+54.0%) | $133.63 M(-10.6%) |
| Sept 2018 | - | $149.53 M(+104.6%) |
| June 2018 | - | $73.08 M(+1.3%) |
| Mar 2018 | - | $72.10 M(-16.9%) |
| Dec 2017 | $86.78 M(+71.1%) | $86.78 M(-12.4%) |
| Sept 2017 | - | $99.07 M(-9.3%) |
| June 2017 | - | $109.22 M(+273.2%) |
| Mar 2017 | - | $29.27 M(-42.3%) |
| Dec 2016 | $50.73 M(-51.7%) | $50.73 M(-29.4%) |
| Sept 2016 | - | $71.80 M(-13.1%) |
| June 2016 | - | $82.59 M(-13.0%) |
| Mar 2016 | - | $94.93 M(-9.6%) |
| Dec 2015 | $105.04 M(+103.3%) | $105.04 M(-7.7%) |
| Sept 2015 | - | $113.86 M(+168.1%) |
| June 2015 | - | $42.47 M(-10.4%) |
| Mar 2015 | - | $47.42 M(-8.2%) |
| Dec 2014 | $51.66 M(+348.8%) | $51.66 M(-6.6%) |
| Sept 2014 | - | $55.34 M(-10.1%) |
| June 2014 | - | $61.57 M(-4.9%) |
| Mar 2014 | - | $64.73 M(+462.3%) |
| Dec 2013 | $11.51 M(+372.0%) | $11.51 M(-15.3%) |
| Sept 2013 | - | $13.59 M(+457.2%) |
| Dec 2012 | $2.44 M(-60.0%) | $2.44 M |
| Dec 2011 | $6.10 M | - |
FAQ
- What is Cara Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Cara Therapeutics?
- What is Cara Therapeutics annual shareholders equity year-on-year change?
- What is Cara Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cara Therapeutics?
- What is Cara Therapeutics quarterly shareholders equity year-on-year change?
What is Cara Therapeutics annual stockholders equity?
The current annual shareholders equity of CARA is $57.09 M
What is the all time high annual shareholders equity for Cara Therapeutics?
Cara Therapeutics all-time high annual stockholders equity is $249.00 M
What is Cara Therapeutics annual shareholders equity year-on-year change?
Over the past year, CARA annual stockholders equity has changed by -$101.69 M (-64.05%)
What is Cara Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CARA is $707.00 K
What is the all time high quarterly shareholders equity for Cara Therapeutics?
Cara Therapeutics all-time high quarterly stockholders equity is $249.00 M
What is Cara Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CARA quarterly stockholders equity has changed by -$84.94 M (-99.17%)